✦ LIBER ✦

Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura

✍ Scribed by Spero R. Cataland; Flora Peyvandi; Pier M. Mannucci; Bernhard Lämmle; Johanna A. Kremer Hovinga; Samuel J. Machin; Marie Scully; Gail Rock; James C. Gilbert; Shangbin Yang; Haifeng Wu; Bernd Jilma; Paul Knoebl

Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 746 KB
Volume: 87
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.23106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LJP 394 for the prevention of renal flar

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study

✍ Donato Alarcón-Segovia; James A. Tumlin; Richard A. Furie; James D. McKay; Mario 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 2 views

## Abstract ## Objective To determine whether LJP 394 delays or prevents renal flare in patients with systemic lupus erythematosus (SLE) and a history of renal disease. ## Methods In a 76‐week, double‐blind, placebo‐controlled study, 230 SLE patients were randomized to receive 16 weekly doses of